Abstract

The fragile X mental retardation (FMR1) gene contains an expansion-prone CGG repeat within its 5′ UTR. Alleles with 55–200 repeats are known as premutation (PM) alleles and confer risk for one or more of the FMR1 premutation (PM) disorders that include Fragile X-associated Tremor/Ataxia Syndrome (FXTAS), Fragile X-associated Primary Ovarian Insufficiency (FXPOI), and Fragile X-Associated Neuropsychiatric Disorders (FXAND). PM alleles expand on intergenerational transmission, with the children of PM mothers being at risk of inheriting alleles with > 200 CGG repeats (full mutation FM) alleles) and thus developing Fragile X Syndrome (FXS). PM alleles can be somatically unstable. This can lead to individuals being mosaic for multiple size alleles. Here, we describe a detailed evaluation of somatic mosaicism in a large cohort of female PM carriers and show that 94% display some evidence of somatic instability with the presence of a series of expanded alleles that differ from the next allele by a single repeat unit. Using two different metrics for instability that we have developed, we show that, as with intergenerational instability, there is a direct relationship between the extent of somatic expansion and the number of CGG repeats in the originally inherited allele and an inverse relationship with the number of AGG interruptions. Expansions are progressive as evidenced by a positive correlation with age and by examination of blood samples from the same individual taken at different time points. Our data also suggests the existence of other genetic or environmental factors that affect the extent of somatic expansion. Importantly, the analysis of candidate single nucleotide polymorphisms (SNPs) suggests that two DNA repair factors, FAN1 and MSH3, may be modifiers of somatic expansion risk in the PM population as observed in other repeat expansion disorders.

Details

Title
Both cis and trans-acting genetic factors drive somatic instability in female carriers of the FMR1 premutation
Author
Hwang, Ye Hyun 1 ; Hayward, Bruce Eliot 2 ; Zafarullah, Marwa 1 ; Kumar, Jay 1 ; Durbin Johnson, Blythe 3 ; Holmans, Peter 4 ; Usdin, Karen 2 ; Tassone, Flora 5 

 University of California Davis, School of Medicine, Department of Biochemistry and Molecular Medicine, Sacramento, USA (GRID:grid.27860.3b) (ISNI:0000 0004 1936 9684) 
 National Institutes of Health, Laboratory of Molecular and Cellular Biology, National Institute of Diabetes, Digestive and Kidney Diseases, Bethesda, USA (GRID:grid.94365.3d) (ISNI:0000 0001 2297 5165) 
 University of California, Davis, School of Medicine, Department of Public Health Sciences, Sacramento, USA (GRID:grid.27860.3b) (ISNI:0000 0004 1936 9684) 
 Cardiff University, Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurology, School of Medicine, Cardiff, UK (GRID:grid.5600.3) (ISNI:0000 0001 0807 5670) 
 University of California Davis, School of Medicine, Department of Biochemistry and Molecular Medicine, Sacramento, USA (GRID:grid.27860.3b) (ISNI:0000 0004 1936 9684); MIND Institute, University of California Davis Medical Center, Sacramento, USA (GRID:grid.413079.8) (ISNI:0000 0000 9752 8549) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2679000291
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.